Vinehealth has raised $5.5m in seed funding. The round was led by Talis Capital, with participation from previous investors Playfair Capital and Ascension. 

As the UK experiences record waiting times for diagnostic imaging, Digital Health startup, National MRI has raised $2.5m seed led by Oxford Capital, YZR, Founders Factory, KM Capital and well-known industry angels Tom Blomfield, Evelyne Bourke (ex-BUPA CEO) and Harry Hurst (PIPE CEO).

Neurovalens, a global leader in non-invasive neuro-technology, has secured new funding towards the development of mental health treatments that target Generalised Anxiety Disorder, Insomnia and Post Traumatic Stress Disorder (PTSD).

British Patient Capital has participated in Quell Therapeutics’ $156m Series B funding round. The deal is the first life sciences  investment from Future Fund: Breakthrough, a £375m programme where British Patient Capital co-invests with private sector investors in innovative R&D-intensive UK companies.

Award-winning medtech firm, Glyconics© has secured £1.5million in an Enterprise Investment Scheme (EIS) funding round ahead of a series A round next year. The innovative diagnostics startup, with offices in Cambridge, Norwich and Basingstoke, raised well over the intended £850k in a raise led by investment platform Wealth Club and existing investors, Deepbridge Capital and Boundary Capital. Demand from Wealth Club private investors and angel investors pushed the total amount further to £1.5 million.

Charco Neurotech, a medical technology company that develops solutions for people with Parkinson’s, has raised $10m seed investment round, co-led by technology investors Amadeus Capital Partners and Parkwalk Advisors, and joined by University of Tokyo Edge Capital Partners (UTEC), MINT Venture Partners, and existing investors, including Crista Galli Ventures. The financing is the largest European seed round in 2021 and the sixth largest globally for healthtech devices, according to Pitchbook.

Charco is a multi-award winning, Imperial College spinout. Its first therapeutic device, CUE1, provides life-changing neuromodulation therapy.

Gentronix, the UK-based contract research organisation (CRO) that is a leader in the field of genetic toxicology, has raised £700,000 in a funding round led by existing investor Mercia to support its continued growth.

Kernel Capital portfolio company B-Secur Ltd, a Belfast-based health tech company, has completed a total raise of £8.8 million (USD $12 million) of investment in 2021, with the latest round led by US-based First Capital Ventures and The Bank of Ireland Kernel Capital Growth Fund NI increasing its investment level to £2.2M with other existing investors also participating.

Chepstow based health tech firm Forth is set to capitalise on the growth in the female science and technology market as it has secured £1.6m funding to support the launch of its ground-breaking female health product. Leading the team at Forth is CEO and Co-Founder Sarah Bolt. She said: “Today, more and more people are realising that understanding and measuring your body’s biochemistry is key for a long and healthy life. For women in particular, gaining unique insight into how their hormone levels fluctuate throughout their unique cycle can give women the support they have been lacking and help to close the gender health gap”. 

Closed Loop Medicine, the global leader in the development of single prescription drug plus digital therapy (DTx) combination products to enable precision dosing, has closed a £13 million financing. 

Dr Louise Rix, a former VC at Forward Partners, is stepping into the start-up world and taking up a new role as Chief Medical Officer at femtech start-up Béa Fertility. 

Maven Capital Partners, one of the UKs most active investors in growing businesses,  has invested £3.25 million in London-based RwHealth